NDC 50242-145 – Perjeta
Pertuzumab 30 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC50242-145
Product details
- Brand name
- Perjeta
- Generic name
- Pertuzumab
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA125409
- Marketed since
- June 8, 2012
- Listing expires
- December 31, 2027
- Pharmacologic class
- HER2/neu Receptor Antagonist
Active ingredients
- Pertuzumab 30 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-145-01 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE | Jun 8, 2012 |